Akorn Inc - Strategic SWOT Analysis Review

December 2021 | 36 pages | ID: A5D429FD2CEAEN
GlobalData

Abstracts

Akorn Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Akorn Inc (Akorn) develops, manufactures, and commercializes generic and branded prescription pharmaceuticals and branded and over-the-counter consumer health products and animal health pharmaceuticals. The company offers its products in both sterile and non-sterile dosage forms including oral liquids, otics, ophthalmics, injectables, topicals, inhalants, and nasal sprays. It also offers contract manufacturing services. Akorn caters to physicians, surgery centers, clinics, optometrists, hospitals, long-term care, wholesalers, retail pharmacies, group purchasing organizations and other pharmaceutical companies. The company has manufacturing facilities in India and the US. It operates in the US, Canada, Mauritius, Luxembourg, Switzerland and India. Akorn is headquartered in Lake Forest, Illinois, the US.

Akorn Inc Key Recent Developments

May 28,2021: Prestige to acquire Akorn’s consumer product portfolio for $230m
May 10,2021: Akorn announces two key executive appointments
Oct 28,2020: Akorn announces its new Board of Directors
Sep 02,2020: Akorn receives court approval of sale to lenders
Aug 07,2020: Akorn provides second quarter 2020 results

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Akorn Inc - Key Facts
Akorn Inc - Key Employees
Akorn Inc - Key Employee Biographies
Akorn Inc - Major Products and Services
Akorn Inc - History
Akorn Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
Akorn Inc - Business Description
Akorn Inc - Corporate Strategy
Akorn Inc - SWOT Analysis
SWOT Analysis - Overview
Akorn Inc - Strengths
Akorn Inc - Weaknesses
Akorn Inc - Opportunities
Akorn Inc - Threats
Akorn Inc - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Akorn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Akorn Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Akorn Inc, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

May 10, 2021: Akorn announces two key executive appointments
Oct 28, 2020: Akorn announces its new Board of Directors
Sep 02, 2020: Akorn receives court approval of sale to lenders
Aug 07, 2020: Akorn provides second quarter 2020 results
May 20, 2020: Akorn to use Voluntary Chapter 11 process to position business for long-term success
May 11, 2020: Akorn provides first quarter 2020 results
Feb 26, 2020: Akorn provides fourth quarter and full year 2019 results

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Akorn Inc, Key Facts
Akorn Inc, Key Employees
Akorn Inc, Key Employee Biographies
Akorn Inc, Major Products and Services
Akorn Inc, History
Akorn Inc, Other Locations
Akorn Inc, Subsidiaries
Akorn Inc, Joint Venture
Akorn Inc, Key Competitors
Akorn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Akorn Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Akorn Inc, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Akorn Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Akorn Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021